Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelled”
An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus
ClinicalTrials.gov study NCT05645432. IPD Sharing: NO. Countries: 1. Publications: 1.
Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT01660451. IPD Sharing: NO. Countries: 25. Publications: 3.
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
ClinicalTrials.gov study NCT00844428. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
ClinicalTrials.gov study NCT00844545. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)
ClinicalTrials.gov study NCT03363841. IPD Sharing: UNDECIDED. Countries: 4. Publications: 2.
Long-Term, Open Label Atomoxetine Study
ClinicalTrials.gov study NCT00190684. IPD Sharing: Not stated. Countries: 14. Publications: 1.
An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.
ClinicalTrials.gov study NCT02657343. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease
ClinicalTrials.gov study NCT00599196. IPD Sharing: Not stated. Countries: 20. Publications: 1.
Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease
ClinicalTrials.gov study NCT03157037. IPD Sharing: NO. Countries: 5. Publications: 3.
An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees
ClinicalTrials.gov study NCT00686582. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
ClinicalTrials.gov study NCT02219009. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT00597597. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal (Agalsidase Alfa) Enzyme Replacement Therapy in Canadian Patients With Fabry Disease
ClinicalTrials.gov study NCT01298141. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
ClinicalTrials.gov study NCT02393248. IPD Sharing: Not stated. Countries: 2. Publications: 2.
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
ClinicalTrials.gov study NCT01691859. IPD Sharing: YES. Countries: 13. Publications: 2.
An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease
ClinicalTrials.gov study NCT00635427. IPD Sharing: Not stated. Countries: 11. Publications: 3.
Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)
ClinicalTrials.gov study NCT04209634. IPD Sharing: YES. Countries: 3. Publications: 3.
A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
ClinicalTrials.gov study NCT03306043. IPD Sharing: YES. Countries: 13. Publications: 1.
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
ClinicalTrials.gov study NCT00203476. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)
ClinicalTrials.gov study NCT00838513. IPD Sharing: Not stated. Countries: 7. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.